The global demographic shift toward an aging population has positioned cancer as a preeminent challenge in public health, with the incidence of most malignancies increasing precipitously with advancing age. By targeting the bidirectional nexus of cancer and aging, we can pioneer precision interventions to improve outcomes for the growing geriatric oncology population.